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Ab s t r Ac t
Alzheimer’s disease (AD) is a chronic, progressive, neurodegenerative disorder that places a substantial burden on patients, their families, and 
society. AD has no cure, but certain drugs are available, which can slow down the disease progression. During the past years, several agents 
have been approved that enhance cognition and global function of AD patients. The presently available drugs for the treatment of Alzheimer’s 
disease are symptomatic only and produce adverse reactions in patients, thereby having limited scope for the treatment of patients of Alzheimer’s 
syndrome. Herbal therapies for Alzheimer’s disease have become more and more popular in recent years as herbal products have been found 
to be as effective as prescription drugs but also with fewer side effects. This review reveals that some plants and their part used having anti-
Alzheimer’s activity, which is helpful for the researcher to develop new herbal remedies in the treatment and management of Alzheimer‘s disease.
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In t r o d u c t I o n
Alzheimer’s disease (AD) is a chronic, progressive, neurodegenerative 
disorder that places a substantial burden on patients, their families, 
and society. Alzheimer’s disease (AD) is the sixth leading cause of 
all deaths in the United States and the fifth leading cause of death 
in Americans aged 65 and older.1 It is estimated to affect 15-million 
people worldwide. AD is the cause of dementia in the elderly. AD 
is a progressive neurological disorder with a duration of around 
8.5 years between the onset of clinical symptoms and death.2 
According to the free radical hypothesis, the aging process is 
associated with multisystem failure due to oxidative damage caused 
by an imbalance between reactive oxygen species production 
and antioxidant defenses. Cytopathological significances of 
oxidative damages are supported by findings of the upregulation 
of antioxidant enzymes like heme oxygenase-1 and superoxide 
dismutase in neurons of AD. Furthermore, lipid peroxidation (LPO), 
a hallmark of oxidative tissue injury has been found to be elevated 
in AD brain.3 It has been observed that there are seven stages found 
in Alzheimer’s disease. Stage one is normal behavior. Stage two is 
minor memory lapse. In stage three, there is confusion and loss of 
names; this borderline condition which does not necessarily lead to 
Alzheimer’s. Stage four or “mild” Alzheimer’s is the inability to think 
rationally. In stage five, “moderate” Alzheimer’s, the patient can’t 
remember the names of close relatives. In stage six, “moderately 
severe” Alzheimer’s, There is an inability to dress oneself and take 
care of personal needs. In stage seven, there is a loss of speech and 
incontinence. The eighth stage of Alzheimer’sdisease is death.4 
The brain has 100 billion nerve cells (neurons). Each nerve cell 
connects with many others to form communication networks. 
Groups of nerve cells have particular jobs, e.g., some are involved 
in thinking, learning, and remembering while others help us see, 
hear, and smell. Physically, Alzheimer’s is characterized by a massive 
loss of neurons and disrupted signaling between cells in the brain. 
The disease can be diagnosed postmortem by observing tangles 
inside and senile plaques outside cells throughout the brain. 
The major component of the plaque is a small, 40/42-amino acid 
peptide amyloid-beta (Aβ). Aβ, the causative agent in AD, was first 
suggested as the amyloid hypothesis about 15 years ago and is now 
widely accepted among the scientific community. Aβ is an elusive 
entity whose chemical and biological action has been difficult to 
understand. It is not very soluble, cannot crystallize and has a highly 
changeable structure in a solution.5 The presently available drugs 
for the treatment of Alzheimer’s disease are symptomatic only and 
do not alter the course or progression of the underlying disease 
and produce adverse reactions in patients, thereby having limited 
scope for the treatment of patients of Alzheimer’s syndrome.6 
Herbal medicine offers several options to modify the progress and 
symptoms of AD. There has been a new trend in the preparation and 
marketing of drugs based on medicinal plants, and their scientific 
and commercial significance appears to be gathering momentum 
in health-relevant areas. These plant-derived products are carefully 
standardized, and their efficacy and safety for a specific application 
have been demonstrated.7
Ad PAt h o lo g y
At the most basic level, AD results from cell death that can result 
from many different factors. Alzheimer’s brains have low levels 
of acetylcholine (Ach), which can arise from the accumulation of 
beta-amyloid (βA) protein fragments that form hard plaques that 
can, in turn, interfere with the ability of Ach to affect synaptic 
transmission and initiate inflammatory processes that produce 
reactive oxygen species. Research suggests that βA opens channels 
in cell membranes, permitting calcium ions (Ca2+) to enter the 
cell and triggering several processes leading to mitochondrial 
dysfunction, inflammation, and cell death. Some research suggests 
that, in the early stages of AD, βA has an antioxidant function so 
that efforts to reduce it might be counterproductive. Other research 
has found only a weak relationship between the amounts of βA 
and the severity of AD. βA may be the result of the destructive 
chain of events and hence more symptomatic than problematic. 
Another possible cause of cell death in AD is a chemical change 
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in a protein (tau) that keeps microtubules stable. This causes a 
neuron’s microtubules to pair with other tubules producing tau 
(neurofibrillary) tangles that result in tubule disintegration and 
block neurotransmitters, leading to cell death. Reactive oxygen 
speices (oxygen ions, peroxides, and free radicals) can result in 
cell death by initiating a chain reaction that leads to damage 
of cell membranes, mitochondria, lipids, and proteins. Damage 
from toxic excitotoxicity amino acid neurotransmitters, especially 
glutamate, can produce excitotoxicity and cell death. Excitotoxicity 
can occur even with normal glutamate levels if glutamate receptor 
sites become overstimulated. The receptor most involved in 
excitotoxicity is N-methyl-D-aspartic acid (NMDA). If NMDA sites 
are overactivated then high levels of Ca2+ can enter the cell, causing 
a permanent depolarization of the postsynaptic neuron creating 
reactive oxygen species and other substances that may cause cell 
death. Potential mechanisms have also linked excitotoxicity to βA 
and tau tangles. Damage from toxins, chemicals, and trauma can 
produce inflammation, another factor in AD. Inflammation often 
results from persistent oxidative stress, but other determinants 
include βA, protease inhibitors, pentraxins, inflammatory cytokines, 
and prostaglandin-generating cyclooxygenases. Unhealthy 
neurons contain low levels of N-acetyl-aspartate (NAA), which 
may also be an issue. Exposure to pollutants can make the blood-
brain barrier permeable to toxins, thus causing oxidative stress, 
inflammation, and βA accumulation.8
Me d I c I n A l Pl A n ts to tr e At Al z h e I M e r
Ginkgo biloba (Maidenhair tree)
Family: Ginkgoaceae
Ginkgo biloba is an herbal medicine being used in traditional 
Chinese medicine for thousands of years to treat a variety of 
ailments. It has been shown to reduce memory loss, enhance brain 
activity, and to slow down the degenerative effects of Alzheimer’s 
disease.9 An extract of Gingko biloba has been found in several 
studies to improve the symptoms and slow the progression of 
Alzheimer’s disease (AD) similar to prescription drugs such as 
Donepezil or Tactrin, with minimal undesirable side effects. The 
ginkgolides present in Ginkgo biloba possess activities pertinent 
to the disease mechanisms in Alzheimer’s such as antioxidant, 
neuroprotective, and cholinergic activities according to the studies 
conducted by Medical Research Council of New castle General 
Hospital. Ginkgo Biloba improves protection against Aβ protein-
induced oxidative damages (degrading hydrogen peroxide, 
preventing lipids from oxidation, and trapping the reactive oxygen 
species).5
Galanthus nivalis (snowdrop) (Alkaloid-Galantamine)
Family: Liliacea
The chief chemical constituent of the Galanthus nivalis L. (common 
snowdrop) is Galantamine, and this is an isoquinoline alkaloid. 
Acetylcholinesterase (AChE) inhibitors, that are also called 
‘anticholinesterase drugs’, have been recently approved as a 
promising treatment approach for AD. Galanthamine has been 
found to be the long-acting and specific inhibitor of the AChE 
enzyme and to potentiate cholinergic nicotinic neurotransmission 
by allosterically modulating the nicotinic acetylcholine 
receptors, which may be of additional value in the treatment of 
AD.10-11
Melissa officinalis (Lemon Balm)
Family: Lamiaceae
Melissa officinalis was believed to sharpen memory. Melissa 
officinalis has shown to improve cognitive function and to reduce 
agitation in patients with mild to moderate AD. Studies have 
demonstrated M. officinalis causes ACh receptor activity in the 
central nervous system with both nicotinic and muscarinic binding 
properties.5 The ethanolic extracts of M. officinalis, magnolol, and 
honokiol, are reported to have antioxidant activity in vitro and 
in vivo.12
Huperzia serrata (firmosses)
Family: Licopodiaceae
H. serrata (Thunb. ex Murray) is one of the genera in the 
Huperziaceae family (Syn. Lycopodiaceae family). This genus has 
been used for its memory-enhancing effect since ages in the 
Traditional Chinese Medicinal system (TCM), and is known to 
contain a large group of alkaloids called ‘Lycopodium alkaloids’. 
Huperzine A, a novel Lycopodium alkaloid extracted from Huperzia 
serrata, is well known as a reversible, potent, and selective AChE 
inhibitor. It is also known as ‘Qian Ceng Ta’ in China, and Huperzine 
A has been used as a therapeutic agent for AD from centuries. 
Research has also shown that Huperzine-A substantially reduces the 
abnormally high radical activity both in the brains of elderly animals 
as well as in the blood of Alzheimer’s patients. An experimental 
study in monkeys has shown that it reverses scopolamine-
induced amnesia, suggesting that it may benefit the cognitive 
problems in Alzheimer’s patients or those with other cognitive 
disorders.13
Commiphora wighitti (Guggul or Mukul myrrh tree)
Family: Burseraceae
It is a shrub or small tree, reaching a maximum height of 4 m, with 
thin papery bark. The active ingredient in the extract is the steroid 
guggulsterone, which acts as an antagonist of the farnesoid X 
receptor. The guggulipid shows potential cognitive enhancers 
for improving memory in scopolamine-induced memory deficits. 
The Commiphora whighittiacting on impairment in learning and 
memory and decreased choline acetyltransferase levels in the 
hippocampus.14
Panax ginseng (Ginseng root)
Family: Araliaceae
Panax Ginseng  (Ren-shen) contains saponins protopanaxadiol, 
protopantriol, and oleanolic acid saponins that are reported to 
have memory-enhancing action for the learning impairment 
induced by scopolamine.  Ginseng grows in Northeastern Asia. 
The Ginseng root has been used in folk medicine in countries 
like China and Korea, for boosting  Qi (energy), from ancient 
time. Ginseng has a history of medicinal use that goes back 
thousands of years. The ginseng extract has many uses, and 
claims to achieve and maintain both physical health and mental 
well-being. Research has also suggested that ginseng is able 
to enhance the psychomotor and cognitive performance, and 
can benefit AD by improving the brain cholinergic function, 
reducing the level of AD, and repairing the damaged neuronal 
networks.15
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Salvia officinalis (Sage)
Family: Lamiaceae
S. officinalis has a very old reputation for improving memory. 
It is singularly good for the head and brain.16 The potential 
pharmacological effects of the herb, which may be relevant to 
AD, include anti-inflammatory and antioxidant properties as 
well as weak AChE inhibitory effect. The leaves of S. officinalis 
L. (sage) are well known for their antioxidative properties.17 
Rosmarinic acid (the main active ingredient of S. officinalis) 
reduced a number of deleterious events induced by Aβ 
include reactive oxygen species formation, lipid peroxidation, 
DNA fragmentation, caspase-3 activation, and tau protein 
hyperphosphorylation.18
Convolvulus pluricaulis Chois. (Shahkpushpi)
Family: Convolvulaceae
C. pluriculis, commonly known as Shahkpushpi, is a fulvous hairy 
herb that has been prescribed by Ayurvedic practitioners for the 
treatment of nervous disorders and as an antiaging remedy.19 
The whole plant in the form of a decoction is used with milk 
and cumin to treat fever, disability, memory loss, syphilis, and 
scrofula.20
Centella asiatica (Mandookparni/ Bramhi)
Family: Umbelliferae
C. asiatica is a slender perennial creeper that grows throughout the 
tropical regions in the world. The leaf, known locally as Gotu Kola, 
has been used in AM for revitalising and strengthening nervous 
function and memory. For example, an Ayurvedic formulation 
composed of 4 herbs, including C. asiatica is used as a restorative 
and for the prevention of dementia. In TCM, it is also used to combat 
physical and mental exhaustion. Aqueous leaf extracts modulated 
dopaminergic, serotonic, and adrenergic systems in vivo and 
improved learning and memory.21
Curcuma longa L. (Turmeric, Harida)
Family: Zingeberaceae
Rhizomes of C. longa, commonly known as turmeric, have been used 
extensively for their culinary properties in Indian cooking and are 
used in AM as a remedy against aging. An aqueous extract of the 
rhizome demonstrated antidepressant activity in mice following 
oral administration, which was associated with inhibition of brain 
MAO type A. Antidepressant activity is of significant importance in 
the management of AD.22
Bacopa monnieri (Linn.) Weltst (Nira Brahmi)
Family: Scrophulariaceae
Goswami  et al. evaluate the effect of Bacopa monnieri  (Brahmi), 
associated with the Ayurveda system of medicine, on the cognitive 
functions in Alzheimer’s disease patients, and conclude that it could 
be beneficial in these patients, but more study is needed.23
Piper nigrum and Piper longum(Black Pepper)
Family: Piperaceae
Piperine, a major alkaloid of black pepper (Piper nigrum Linn.) and 
long pepper (Piper longumLinn.), has been used in folk medicine 
for the treatment of various diseases. Pharmacological studies 
have shown that piperine possesses various activities, including 
anti-inflammatory and analgesic, anticonvulsant, anti-ulcer, anti-
depressant, cytoprotection, antioxidant, and cognitive enhancing 
effect. It inhibits monoamine oxidase (MAO) activity and increases 
the level of noradrenaline and serotonin in the mouse brain, 
indicating its potential neurological benefits. Piperine could 
affect hippocampus neurogenesis in chronic mild stressed mice 
in which the level of brain-derived neurotrophic factor decreased. 
At a dose between 5-20mg/kg body weight given to cholinergic-
deficient rats, induced by AF64A, piperine could attenuate 
the increase in lipid peroxidation and acetylcholinesterase 
activity.24-26
Glycyrrhiza glabra (The Licorice Root)
Family: Fabaceae
AD is characterized by neuronal loss and the presence of 
extracellular senile plaques, whose major constituent is an 
amyloid-β peptide (Aβ). In this study, we investigated the effects 
of a water extract of licorice (Yashti-madhuka) on Aβ25-35-induced 
apoptosis in PC12 cells. Results suggest that Glycyrrhiza exerts a 
protective effect against apoptotic neuronal cell death induced 
by Aβ fragments. Extract from the licorice root is reported to treat 
or even prevent brain cell death in diseases like Alzheimer’s and its 
associated symptoms.27
Withania somnifera (Ashwagandha)
Family: Solanaceae
Withania somnifera (Ashwagandha) has been described as an 
anervine tonic in Ayurveda, and that is why it is a common 
ingredient of Ayurvedic tonic.[6] Active glyco with anolides 
of Withania somnifera  (Ashawgandha) have a signif icant 
antioxidant function, which is accomplished by increasing the 
activities of superoxide dismutase, catalase, and glutathione 
peroxidase.28
Foeniculum vulgare (Fennel)
Family: Umbelliferae
Foeniculum vulgare Linn. Extract used as a nootropic and 
anticholinesterase agent in mice. F. vulgare extract increased 
step-down latency and acetylcholinesterase inhibition in mice 
significantly. F. Vulgare is employed in the treatment of cognitive 
disorders such as dementia and Alzheimer’s disease.29
Lepidium meyenii (Maca)
Family: Brassicaceae
Lipidium meyenni (Brassicaceae), known commonly as maca, is 
an herbaceous biennial plant or annual plant native to the high 
Andes of Peru and Bolivia. It has shown beneficial improvement 
in memory and learning. Aqueous and hydroalcoholic extracts 
of Black Maca have significantly ameliorated the scopolamine-
induced memory impairment in mice.30 Lipidium Meyanii acting on 
cholinergic dysfunction, mainly neurotransmitter (ACh) related to 
memory and learning.31 Black maca (0.5 and 2.0 g/kg) decreased 
brain malondialdehyde (MDA) levels marker of oxidative stress 
and acetylcholinesterase (Ache) levels in ovariectomized mice. 
In contrast, no differences were observed in monoamine oxidase 
(MAO) levels.32
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Celastrus paniculatus (Malkangni)
Family: Celastraceae
The plant C.paniculatus, commonly known as a black-oil tree, is a 
large woody climbing shrub. In India, it is known as Malkangni and 
has been mentioned in ancient Indian literature as an intelligence 
promoter. The seeds and seed oil have been used in AM as a 
memory enhancer, and it was reported that the seed oil reduces 
the levels of noradrenaline, dopamine, and 5-hydroxytryptamine 
(5-HT) in vivo.21 Jothismati oil from seeds of Celastrus paniculatus 
Table 1: Herbs having anti-Alzheimer activity
S.NO Botanical name Family Parts used Extract References
1 Acorus calamus L. Araceae Rhizomes ethanolic and hydroethanolic 12
2 Abutilon indicum Linn. Malvaceae Whole Methanolic 33
3 Abrus precatorius L. Fabaceae Leaves Petroleum ether and ethanolic 34
4 Angelica archangelica L. Umbelliferae Dried roots Methanolic 21
5 Bacopa monnieri  Scrophulariaceae arial parts and 
rhizomes
Ethanolic 21
6 Buxus sempervires Linn Buxaceae Whole Chloroform: methanol (1:1) 35
7 Boerhaavia diffusa Nyctaginaceae Leaves Ethanolic and methanolic 4
8 Carthamus tinctorius Linn. Compositae Flower Methanolic 36
9 Cassia fistula Linn Leguminosae Roots Methanolic 36
10 Catharanthus roseus Apocynaceae Dried root 37
11 Celastrus paniculata Willd. Celastraceae Seeds Aqueous 6,21
12 Clitoria ternatea L. leguminosae Rhizomes and 
arial parts
Ethanolic 21
13 Centella asiatica Linn Umbelliferae Whole Plant Alcoholic and aqueous 21
14 Convolvulus pluricaulis Convolvulaceae whole plant Ethanolic 19,20
15 Crocus sativus L. Iridaceae Pistils and  
stigmas
Alcoholic and  hydroalcoholic 12
16 Commiphora whighitti Burseraceae Whole plant         - 14
17 Cyperus rotundus Linn. Cyperaceae Whole Methanolic 33
18 Curcuma longa Zingiberaceae Rhizomes Aqueous 22
19 Dipsacus asper Wall. Dipsacaceae Root          - 38
20 Evolvulus alsinoides Linn Convolvulaceae Whole Plant Ethanolic, aqueous and ethyl acetate 14
21 Emblica officinalis Euphorbiaceae leaves Methanolic 40
22 Fumaria macrocarpa Boiss. Ex Fumariaceae Whole Chloroform: methanol (1:1) 35
23 Galanthus nivalis Amaryllidaceae Bulbs           - 10,11
24 Ginkgo biloba Ginkgoaceae Leaves Ethanolic 5,9,36
25 Glycyrrhiza glabra Fabaceae Roots Water 27
26 Hypericum perforatum L. Hypericaceae Arial parts Hydroalcoholic extracts 12
27 Ilex paraguariensis Yebra. Aquifoliaceae Leaves          - 14
28 Lycopodium clavatum Linn. Lycopodiaceae Whole Chloroform:methanol (1:1) 36
29 Lepidium meyenii Brassicaceae  dried hypocotyls aqueous and
hydroalcoholic
2
30 Magnolia officinalis Magnoliaceae Stem Ethanolic  39
31 Matricaria recutita Asteraceae Flower         - 15
32 Melissa officinalis Lamiaceae Leaves Volatile oil 5,12
33 Panax Ginseng Araliaceae Roots Aqueous 15
34 Piper interruptum Opiz Piperaceae Stems Methanolic 33
35 Piper nigrum Linn. Piperaceae Seeds Methanolic 33
36 Rosmarinus officinalis Lamiaceae Leaves          - 5
37 Rheum spp L. Polygonaceae Rhizomes Methanolic etract 21
38 Salvia officinalis Lamiaceae  Leaves Ethanol 95% 
Steam distilled oil
16-18
39 Terminalia chebula Linn. Combretaceae Rhizome Methanolic 12
40 Tinospora cordifolia Menispermaceae Alcoholic and aqueous 15
41 Vicia faba Linn. Fabaceae Whole Chloroform:methanol (1:1) 36
42 Withania somnifera Solanaceae  Roots Methanolic 6, 28
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(CP) is used in the indigenous system of medicine for the treatment 
of brain-related disease. It has been described to promote memory 
and to posses various pharmacological activities.6
Tinospora Cordifolia (Guduchi)
Family: Menispermaceae
Tinospora Cordifolia (Guduchi) possesses a memory-enhancing 
property for learning and memory in normal and memory-
deficits animals. Tinospora Cordifolia’s mechanism for cognitive 
enhancement is by immunostimulation and synthesis of 
acetylcholine; this supplementation of choline enhances the 
cognitive function.15
co n c lu s I o n
During the past years, several agents have been approved that 
enhance cognition and global function of AD patients, and recent 
advances in understanding AD pathogenesis has led to the 
development of numerous compounds that might modify the 
disease process. Novel information gathered from the current data 
is important in preserving indigenous folk knowledge as well as in 
the discovery of novel potential compounds with promising Anti-
Alzheimer’s potential. Therefore, this review has been prepared 
to provide a new compilation of plants with specific use as anti- 
Alzheimer’s drugs.  Moreover, this review has incorporated the 
latest data on new plant species, which are not covered in previous 
reviews on AD.
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